Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ekso Bionics Stock Prices Surge Following Q4 Financial Results

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Ekso Bionics is seeing a surge in their stock prices following the release of their Q4 financial results, which were a mixed bag. The company is set to unveil their full financial and business results for the fourth quarter and the entire year of 2023 on March 4, 2024. Analysts are predicting a significant 54.2% increase in EPS and a 34.4% rise in earnings for the company.

Specializing in exoskeleton solutions, Ekso Bionics is renowned for their products that boost strength, endurance, and mobility in both medical and industrial fields. Their innovative wearable robots cater to individuals of all abilities, providing assistance for a wide range of needs from rehabilitation to improving human performance in the workplace.

EKSO Stock Shows Strong Price Momentum on March 4, 2024 – Investors Advised to Monitor Performance

On March 4, 2024, EKSO stock showed positive price momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $2.10, showing a price increase of $0.11 or 5.53% since the market last closed. Despite the positive performance during regular trading hours, EKSO stock experienced a slight drop of $0.04 in after-hours trading. Overall, EKSO stock displayed strong price momentum on March 4, 2024. Investors should continue to monitor the stock’s performance and any potential news or developments that could impact its price in the future.

Ekso Bionics Holdings, Inc. (EKSO) Financial Performance Update March 4, 2024

On March 4, 2024, Ekso Bionics Holdings, Inc. (EKSO) saw mixed performance in its financial metrics. According to data from CNN Money, the company reported total revenue of $12.91 million for the past year, which represented a 14.81% increase compared to the previous year. However, total revenue for the most recent quarter was $4.61 million, which remained flat compared to the previous quarter. In terms of net income, Ekso reported a net loss of $15.08 million for the past year, marking a 54.44% decrease from the previous year. However, the net loss for the most recent quarter improved to $3.37 million, representing a 20.45% increase compared to the previous quarter. Earnings per share (EPS) for Ekso showed a similar trend. The company reported an EPS of -$1.16 for the past year, reflecting a 32.25% decrease from the previous year. However, EPS for the most recent quarter improved to -$0.24, showing a 22.92% increase compared to the previous quarter. Overall, Ekso’s financial performance on March 4, 2024, showed a mixed bag of results. While the company saw improvements in net income and EPS on a quarterly basis, there were declines in these metrics on a yearly basis. The flat total revenue for the most recent quarter may indicate stability in the company’s revenue stream. Investors will likely keep a close eye on Ekso’s future financial reports to see if the company can sustain or improve upon its recent performance.

Tags: EKSO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Albemarle Corporation Announces 175 Billion Depositary Shares Offering with JP Morgan and BofA Securities as Joint BookRunning Managers

Finance_Commercial

Century Communities Inc Announces CFO Transition and Search for Successor

Title Select Water Solutions Announces Executive Reshuffle with Appointment of New CFO

Recommended

IBM Stock

IBM’s Market Conundrum: Strong Fundamentals Clash With Share Price Decline

1 week ago
Red Cat Stock

Red Cat’s Naval Ambitions Meet Investor Skepticism

4 weeks ago
COST stock news

Versus Systems Inc Meets Nasdaqs Minimum Bid Price Requirement

2 years ago
Super Micro Computer Stock

Strategic Nokia Alliance Offers Super Micro a Path Through Governance Challenges

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Insider Sales at Tutor Perini Coincide with Stock Peak

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Trending

Dynex Capital Stock
Analysis

Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio

by Felix Baarz
September 22, 2025
0

A major institutional investor has dramatically increased its stake in mortgage REIT Dynex Capital, even as fundamental...

Pfizer Stock

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

September 22, 2025
Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio
  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com